摘要
《新型冠状病毒肺炎诊疗方案》从试行第一版至第七版,均体现了中医药治疗的积极作用.此次肺炎导致老年人群及基础疾病患者的发病率和致死率较高,这与此类人群体质状况息息相关.本文从肺脾气虚角度认识新型冠状病毒肺炎的发生与发展,强调从轻症阶段开始应关注肺脾气虚病因,并宜早予以对证治疗;针对国家及省市区发布诊疗方案中高频次的六味补气健脾中药,进行成分、抗炎、抗氧化、调节免疫、靶点作用的研究现状综述,以期为临床医生合理使用和药物研发提供参考.
From the Diagnosis and treatment of novel coronavirus pneumonia trail version 1 to Version 7,traditional Chinese medicine has been playing the positive role in treating 2019-nCoV pneumonia.It is found that the older people or people with primary diseases are easily infected by the novel coronavirus with more high mortality,which is related to the special condition of them.Thus,the traditional medicinal theory of lung and spleen Qi deficiency syndrome is applied to learn about the etiology of novel coronavirus pneumonia.Furthermore,six medicines in the Diagnosis and treatment version 7 are reviewed for chemical components,anti-inflammation,antioxidation,regulation of immunity and targeting action.It may provide a guide for clinicians to use and study the medicines.
作者
葛月宾
刘芮
梅之南
GE Yuebin;LIU Rui;MEI Zhinan(School of Pharmaceutical Science, Institute of Ethnic Medicine, South-Central University for Nationalities, Wuhan 430074, China)
出处
《中南民族大学学报(自然科学版)》
CAS
2020年第2期145-150,共6页
Journal of South-Central University for Nationalities:Natural Science Edition
基金
湖北省科技厅新型肺炎应急科技攻关项目(2020FCA042)
中央高校基本科研业务费专项资金资助项目(CZY19031)。
关键词
新型冠状病毒
肺炎
肺脾气虚
中药
2019-nCoV
pneumonia
lung and spleen Qi deficiency syndrome
traditional Chinese medicine